Biocryst Pharmaceuticals Inc (BCRX)
R&D Expenses
$51.97M
Quarterly · Period ending: · USD
BCRX R&D Expenses
Latest reported$51.97Mperiod ending
Latest reported$51.97Mperiod ending
BCRX Quarterly R&D Expenses ($0.00 → $51.97M)
Quarterly R&D Expenses
High-resolution chart · PNG
BCRX r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 51,969,000 | |
| 60,319,000 | |
| 41,202,000 | |
| 44,268,000 | |
| 43,386,000 | |
| 37,270,000 | |
| 49,441,000 | |
| 41,081,000 | |
| 37,623,000 | |
| 46,493,000 | |
| 70,052,000 | |
| 46,879,000 | |
| 51,247,000 | |
| 48,388,000 | |
| 73,207,000 | |
| 52,740,000 | |
| 61,990,000 | |
| 65,360,000 | |
| 63,529,000 | |
| 49,971,000 | |
| 52,873,000 | |
| 42,435,000 | |
| 35,354,000 | |
| 30,245,000 | |
| 27,498,000 | |
| 29,867,000 | |
| 26,774,000 | |
| 25,120,000 | |
| 27,681,000 | |
| 27,493,000 | |
| 23,431,000 | |
| 22,006,000 | |
| 21,010,000 | |
| 18,441,000 | |
| 16,924,000 | |
| 17,509,000 | |
| 15,759,000 | |
| 16,770,000 | |
| 12,158,000 | |
| 14,105,000 | |
| 14,166,000 | |
| 20,579,000 | |
| 19,047,000 | |
| 20,067,000 | |
| 16,524,000 | |
| 17,120,000 | |
| 18,510,000 | |
| 13,036,000 | |
| 11,067,000 | |
| 9,183,000 | |
| 15,614,000 | |
| 7,977,000 | |
| 11,728,000 | |
| 7,411,000 | |
| 11,090,000 | |
| 12,072,000 | |
| 12,777,000 | |
| 15,441,000 | |
| 15,211,000 | |
| 14,772,000 | |
| 13,975,000 | |
| 12,932,000 | |
| 23,622,014 | |
| 19,197,000 | |
| 14,737,000 | |
| 24,917,000 | |
| 31,618,442 | |
| 18,181,000 | |
| 11,213,000 | |
| 11,289,000 | |
| 22,059,634 | |
| 15,996,000 | |
| 13,373,000 | |
| 21,898,000 | |
| 29,113,996 | |
| 29,730,000 | |
| 19,013,000 | |
| 16,195,000 | |
| 11,199,372 | |
| 16,650,000 | |
| 11,190,000 | |
| 8,043,000 | |
| 6,040,377 | |
| 7,164,000 | |
| 5,263,000 | |
| 5,175,000 | |
| 4,700,112 | |
| 4,838,000 | |
| 4,348,000 | |
| 4,983,000 | |
| 2,963,000 | |
| 3,105,000 | |
| 2,965,000 | |
| 2,489,000 | |
| 2,538,491 | |
| 3,172,000 | |
| 4,377,000 | |
| 5,387,000 | |
| 5,018,057 | |
| 2,830,000 |